Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

      Manufacturing
      Rentschler Fill Solutions GmbH, a contract development and manufacturing organization (CDMO) and expert for aseptic filling and finishing of biopharmaceuticals, received notification from the...

      ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

      Drug Development
      ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company...

      DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

      FDA Approvals
       DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases...

      Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

      Manufacturing
      Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...

      LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

      Clinical Trials
      LexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced  it has an agreement...

      Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

      FDA Approvals
      Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced that the U.S. FDA...

      Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome

      FDA Approvals
      Stoke Therapeutics, Inc , a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.